فاس نيوز ميديا جريدة الكترونية جهوية تعنى بشؤون و أخبار جهة فاس مكناس – متجددة على مدار الساعة
According to a report published by the newspaper “Al Ayyam”, the high prices accompanying the sale of medicines in Morocco are mainly due to the marketing of original drugs, and not generic drugs whose prices are occasionally announced to be reduced.
A well-informed source pointed out that the decree issued in 2013, which compares drug prices in Morocco with their prices in other countries such as Turkey, Belgium, Saudi Arabia, Spain, France and Portugal, is unrealistic, given the differences in levels of social welfare and individual income between these countries and Morocco.
Amin Bouzaib, the Secretary-General of the Confederation of Pharmacists’ Unions in Morocco, revealed that pharmacists are incurring losses due to the repeated reductions in the prices of generic drugs, which may lead to their disappearance from the market. In contrast, he indicated that the companies marketing the original drugs are the biggest beneficiaries of this high price.
Deputy Abdullah Bouanaw affirmed that some players entered the pharmaceutical industry with the aim of profiting at the expense of the health of citizens. Ali Loutfi, President of the Moroccan Network for the Defense of the Right to Health, also stressed that the government has acknowledged the unacceptable rise in drug prices.
Dr. Abdelhafeez Lalou, an expert in health economics, explained that the repeated reductions in drug prices have become a threat to the continuity of thousands of pharmacies in providing their services to citizens.
